| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $359.4M | -58.8% |
| Gross Profit | $80.0M | +109.1% |
| R&D Expense | $100K | -83.3% |
| Operating Income | -$321.6M | -9362.2% |
| Pre-tax Income | -$346.1M | -9455.8% |
| Income Tax | $5.0M | +72.1% |
| Net Income | -$351.1M | -2739.4% |
| EPS (Basic) | -$29.88 | -7387.8% |
| EPS (Diluted) | -$29.88 | -7387.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.1M | +206.7% |
| Accounts Receivable | $130.3M | +557.7% |
| Inventory | $11.4M | +197.3% |
| Current Assets | $239.7M | +480.0% |
| Total Assets | $902.1M | +924.6% |
| Current Liabilities | $322.0M | +368.3% |
| Long-term Debt | $387.6M | +1240.1% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.2M | +448.8% |
| Capital Expenditures | $5.8M | +359.4% |
| Investing Cash Flow | -$6.3M | -270.5% |
| Financing Cash Flow | $13.1M | +5.3% |
| Free Cash Flow | $12.4M | +291.5% |
| $814.8M |
| +644.8% |
| Stockholders' Equity | $87.3M | +509.2% |